356
Views
78
CrossRef citations to date
0
Altmetric
Review

Placenta-derived exosomes: potential biomarkers of preeclampsia

, , &
Pages 8009-8023 | Published online: 31 Oct 2017

References

  • American College of Obstetricians and GynecologistsHypertension in pregnancyObstet Gynecol20131221122113124150027
  • KuklinaEAyalaCCallaghanWHypertensive disorders and severe obstetric morbidity in the United StatesObstet Gynecol20091131299130619461426
  • WagnerLKDiagnosis and management of pre-eclampsiaAm Fam Physician2004702317232415617295
  • RedmanCWCurrent topic: pre-eclampsia and the placentaPlacenta1991123013081946241
  • BurtonGJJauniauxEPlacental oxidative stress: from miscarriage to preeclampsiaJ Soc Gynecol Investig200411342352
  • KnightMRedmanCWLintonEASargentILShedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnanciesBr J Obstet Gynaecol19981056326409647154
  • RedmanCWSargentILPlacental debris, oxidative stress and pre-eclampsiaPlacenta20002159760210985960
  • RedmanCWSargentILMicroparticles and immunomodulation in pregnancy and pre-eclampsiaJ Reprod Immunol200776616717482271
  • RedmanCWSargentILPre-eclampsia, the placenta and the maternal systemic inflammatory response: a reviewPlacenta200324S21S2712842410
  • SargentILGermainSLSacksGPKumarSRedmanCWTrophoblast deportation and the maternal inflammatory response in pre-eclampsiaJ Reprod Immunol20035915316012896819
  • GermainSJSacksGPSoorannaSRSargentILRedmanCWSystemic inflammatory priming in normal pregnancy and preeclampsia. the role of circulating syncytiotrophoblast microparticlesJ Immunol20071785949595617442979
  • SouthcombeJTannettaDRedmanCSargentIThe immunomodulatory role of syncytiotrophoblast microvesiclesPLoS One20116e2024521633494
  • TannettaDMasliukaiteIVatishMRedmanCSargentIUpdate of syncytiotrophoblast derived extracellular vesicles in normal pregnancy and preeclampsiaJ Reprod Immunol20171199810627613663
  • TannettaDCollettGVatishMRedmanCSargentISyncytiotrophoblast extracellular vesicles: circulating biopsies reflecting placental healthPlacenta20175213413827899180
  • RedmanCWSargentILLatest advances in understanding preeclampsiaPlacenta2005172127
  • RedmanCWSargentILCirculating microparticles in normal pregnancy and pre-eclampsiaPlacenta200829S73S7718192006
  • SargentILBorzychowskiAMRedmanCWImmunoregulation in normal pregnancy and pre-eclampsia: an overviewReprod Biomed Online20061368068617169180
  • TannettaDSDragovicRAGardinerCRedmanCWSargentILCharacterisation of syncytiotrophoblast vesicles in normal pregnancy and preeclampsia: expression of Flt-1 and endoglinPLoS One20138e5675423437230
  • TannettaDSHuntKJonesCISyncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet functionPLoS One201510e014253826551971
  • TranquilliALDekkerGMageeLThe classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHPPregnancy Hypertens201449710426104417
  • MageeLAHelewaMMoutquinJMvon DadelszenPDiagnosis, evaluation, and management of the hypertensive disorders of pregnancyJ Obstet Gynaecol Can200830S1S4818817592
  • HuppertzBPlacental origins of preeclampsia: challenging the current hypothesisHypertension200851497097518259009
  • TranquilliALBrownMAZeemanGGDekkerGSibaiBMThe definition of severe and early-onset preeclampsia: statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Pregnancy Hypertens20133444726105740
  • LisonkovaSJosephKSIncidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset diseaseAm J Obstet Gynecol2013209544.e1544.e1223973398
  • MageeLAPelsAHelewaMReyEvon DadelszenPDiagnosis, evaluation, and management of the hypertensive disorders of pregnancyPregnancy Hypertens2014410514526104418
  • No authors listedHypertension: management of hypertensive disorders of pregnancy according to international guidelines – a panel discussion (case 5: postpartum eclampsia)Am J Perinatol Epub201565
  • Biomarkers Definitions Working GroupBiomarkers and surrogate endpoints: preferred definitions and conceptual frameworkClin Pharmacol Ther200169899511240971
  • MageeLAPelsAHelewaMReyEvon DadelszenPDiagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summaryJ Obstet Gynaecol Can20143641644124927294
  • ScazzocchioEFiguerasFCrispiFPerformance of a first-trimester screening of preeclampsia in a routine care low-risk settingAm J Obstet Gynecol2013208203.e1203.e1023246313
  • ParkFJLeungCHPoonLCWilliamsPFRothwellSJHyettJAClinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancyAust N Z J Obstet Gynaecol20135353253923919594
  • PoonLCKametasNAMaizNAkolekarRNicolaidesKHFirst-trimester prediction of hypertensive disorders in pregnancyHypertension20095381281819273739
  • WangARanaSKarumanchiSAPreeclampsia: the role of angiogenic factors in its pathogenesisPhysiology (Bethesda)20092414715819509125
  • MaynardSEMinJYMerchanJExcess placental soluble Fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJ Clin Invest200311164965812618519
  • AhmadSAhmedAElevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsiaCirc Res20049588489115472115
  • VerlohrenSHerraizILapaireOThe sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patientsAm J Obstet Gynecol201220658.e1e822000672
  • VerlohrenSStepanHDechendRAngiogenic growth factors in the diagnosis and prediction of pre-eclampsiaClin Sci (Lond)20121124352
  • StepanHHerraizISchlembachDImplementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practiceUltrasound Obstet Gynecol20154524124625736847
  • VerlohrenSHerraizILapaireONew gestational phase-specific cutoff values for the use of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsiaHypertension20146334635224166751
  • TsatsarisVGoffinFMunautCBrichantJFPignonMRNoelAOverexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequencesJ Clin Endocrinol Metab2003885555556314602804
  • LevineRJMaynardSEQianCCirculating angiogenic factors and the risk of preeclampsiaN Engl J Med200435067268314764923
  • VerlohrenSHerraizILapaireOThe routine measurement of the sFlt1/PlGF ratio allows differential diagnosis of hypertensive pregnancy disorders and has prognostic potential in preeclamptic patientsPregnancy Hypertens20111245246
  • VerlohrenSGalindoASchlembachDAn automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsiaAm J Obstet Gynecol2010202161.e1161.e1119850276
  • RobinsonCJJohnsonDDSoluble endoglin as a second-trimester marker for preeclampsiaAm J Obstet Gynecol2007197174.e1e517689640
  • VenkateshaSToporsianMLamCSoluble endoglin contributes to the pathogenesis of preeclampsiaNat Med20061264264916751767
  • LevineRJMaynardSEQianCCirculating angiogenic factors and the risk of preeclampsiaN Engl J Med200435067268314764923
  • KleinrouwelerCEWiegerinckMMRis-StalpersCAccuracy of circulating placental growth factor, vascular endothelial growth factor, soluble Fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysisBJOG2012119777878722433027
  • MartinAKrishnaIBadellMSamuelACan the quantity of cell-free fetal DNA predict preeclampsia? A systematic reviewPrenat Diagn201434686691
  • HahnSRusterholzCHösliILapaireOCell-free nucleic acids as potential markers for preeclampsiaPlacenta201132S17S2021257079
  • SalviantiFInversettiASmidMProspective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsiaPlacenta201536996100126183647
  • YuHShenYGeQQuantification of maternal serum cell-free fetal DNA in early-onset preeclampsiaInt J Mol Sci2013147571758223567271
  • PapantoniouNBagiokosVAgiannitopoulosKKolialexiADestouniATountaGRASSF1A in maternal plasma as a molecular marker of preeclampsiaPrenat Diagn20133368268723526657
  • KolialexiATountaGApostolouPEarly non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCREur J Obstet Gynecol Reprod Biol2012161343722261468
  • ConkaJKonečnáBLaukováLVlkováBCelecPFetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mousePlacenta20175210010528454691
  • Perez-SepulvedaATorresMJKhouryMIllanesSEInnate immune system and preeclampsiaFront Immunol2014524424904591
  • KumarABegumNPrasadSAgarwalSSharmaSIL-10, TNF-α & IFN-γ: potential early biomarkers for preeclampsiaCell Immunol2013283707423880295
  • OpsjlnSLWathenNCTingulstadSTumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancyAm J Obstet Gynecol19931693974048362955
  • WegmannTGLinHGuilbertLMosmannTRBidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?Immunol Today1993143533568363725
  • AfshariJTGhomianNShameliADetermination of interleukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsiaBMC Pregnancy Childbirth200551416259641
  • ChenQWangYZhaoMHyettJCostaFSNieGSerum levels of GDF15 are reduced in preeclampsia and the reduction is more profound in late-onset than early-onset casesCytokine20168322623027173615
  • NieGLiYHaleKSerine peptidase HTRA3 is closely associated with human placental development and is elevated in pregnancy serumBiol Reprod20067436637416251496
  • LiYPuryerMLinEPlacental HTRA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsiaJ Clin Endocrinol Metab20119640341121047919
  • WangYLiYHyettJCostaFSNieGHTRA3 isoform-specific ELISAs for early detection of preeclampsiaJ Biomol Screen Epub2016128
  • PetersonSESimhanHNFirst-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growthAm J Obstet Gynecol2008198e43e4518295168
  • LawrenceJBOxvigCOvergaardMTThe insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-AProc Natl Acad Sci U S A1999963149315310077652
  • ZwahlenMGerberSBersingerNAFirst trimester markers for pre-eclampsia: placental vs. non-placental protein serum levelsGynecol Obstet Invest200763152116864982
  • D’AnnaRBavieraGGiordanoDTodarelloGCorradoFBuemiMSecond trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsiaActa Obstet Gynecol Scand2008871370137318951213
  • ChakrabortySKaurSGuhaSBatraSKThe multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerBiochim Biophys Acta2012182612916922513004
  • BredakiFEMataliotakisMWrightAWrightDNicolaidesKHMaternal serum alpha-fetoprotein at 12, 22 and 32 weeks’ gestation in screening for pre-eclampsiaUltrasound Obstet Gynecol20164746647126582719
  • HawfieldAFreedmanBIPre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detectionTher Adv Cardiovasc Dis20093657319124387
  • ThanNGBaloghARomeroRPlacental protein 13 (PP13): a placental immunoregulatory galectin protecting pregnancyFront Immunol2014534825191322
  • ThanNGRomeroRKimCJMcGowenMRPappZWildmanDEGalectins: guardians of eutherian pregnancy at the maternal-fetal interfaceTrends Endocrinol Metab201223233122036528
  • WortelboerEJKosterMPCuckleHSStoutenbeekPHSchielenPCVisserGHFirst-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsiaBJOG20101171384138920840693
  • SouthcombeJTannettaDRedmanCSargentIThe immunomodulatory role of syncytiotrophoblast microvesiclesPLoS One20116e2024521633494
  • LeeSMRomeroRLeeYJParkISParkCWYoonBHSystemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsiaAm J Obstet Gynecol20122074337.e1e823021701
  • GoswamiDTannettaDSMageeLAExcess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restrictionPlacenta200627566116310038
  • AnandSYoungSEsplinMSDetection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometryJ Lipid Res20165768769626891737
  • WitwerKWBuzásEIBemisLTStandardization of sample collection, isolation and analysis methods in extracellular vesicle researchJ Extracell Vesicles2013220360
  • ThéryCAmigorenaSRaposoGClaytonAIsolation and characterization of exosomes from cell culture supernatants and biological fluidsCurr Protoc Cell Biol20063129
  • SalomonCScholz-RomeroKSarkerSGestational diabetes mellitus is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestationDiabetes20166559860926718504
  • SalomonCTorresMJKobayashiMA gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migrationPLoS One20149e9866724905832
  • SarkerSScholz-RomeroKPerezAPlacenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancyJ Transl Med20141220425104112
  • StenqvistACNagaevaOBaranovVMincheva-NilssonLExosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetusJ Immunol20131915515552324184557
  • SabapathaAGercel-TaylorCTaylorDDSpecific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequencesAm J Reprod Immunol20065634535517076679
  • CarayonKChaouiKRonzierEProteolipidic composition of exosomes changes during reticulocyte maturationJ Biol Chem2011286344263443921828046
  • PillayPMaharajNMoodleyJMackrajIPlacental exosomes and pre-eclampsia: maternal circulating levels in normal pregnancies and early and late onset pre-eclamptic pregnanciesPlacenta201646182527697217
  • DragovicRACollettGPHolePIsolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence nanoparticle tracking analysisMethods201587647425843788
  • DragovicRAGardinerCBrooksASSizing and phenotyping of cellular vesicles using nanoparticle tracking analysisNanomedicine2011778078821601655
  • TannettaDSDragovicRAGardinerCRedmanCWSargentILCharacterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglinPLoS One20138e5675423437230
  • WilliamsJLGatsonNNSmithKMAlmadAMcTigueDMWhitacreCCSerum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunityClin Immunol201314923624323706172
  • SalomonCRyanJSobreviaLExosome signalling during hypoxia mediates microvascular endothelial cell migration and vasculogenesisPLoS One20138e6845123861904
  • FrängsmyrLBaranovVNagaevaOCytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular levelMol Hum Reprod200511354115579659
  • AbrahamsVMStraszewski-ChavezSLGullerSMorGFirst trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosisMol Hum Reprod2004101556314665707
  • KshirsagarSKAlamSMJastiSImmunomodulatory molecules are released from the first trimester and term placenta via exosomesPlacenta2012331298299023107341
  • SalomonCRiceGERole of exosomes in placental homeostasis and pregnancy disordersProg Mol Biol Transl Sci201714516317928110750
  • BeachAZhangHGRatajczakMZKakarSSExosomes: an overview of biogenesis, composition and role in ovarian cancerJ Ovarian Res201471424460816
  • HedlundMStenqvistACNagaevaOHuman placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive functionJ Immunol200918334035119542445
  • VargasAZhouSEthier-ChiassonMSyncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with pre-eclampsiaFASEB J2014283703371924812088
  • Mincheva-NilssonLBaranovVThe role of placental exosomes in reproductionAm J Reprod Immunol20106352053320331583
  • MakiyaRStigbrandTPlacental alkaline phosphatase is related to human IgG internalization in HEp2 cellsBiochem Biophys Res Commun19921826246301531173
  • GoetzlLDarbinianNGoetzlEJNovel window on early human neurodevelopment via fetal exosomes in maternal bloodAnn Clin Transl Neurol2016338138527231707
  • YuBZhangXLiXExosomes derived from mesenchymal stem cellsInt J Mol Sci2014154142415724608926
  • TomasettiMLeeWSantarelliLNeuzilJExosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapyExp Mol Med201749e28528104913
  • ZhouSAbdouhMArenaVArenaMArenaGOReprogramming malignant cancer cells toward a benign phenotype following exposure to human embryonic stem cell microenvironmentPLoS One201712e016989928068409
  • BrunoSPortaSBussolatiBExtracellular vesicles in renal tissue damage and regenerationEur J Pharmacol2016790839127375075
  • AmarnathSFoleyJEFarthingDEBone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivoStem Cells2015331200121225532725
  • LasserCExosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicleExpert Opin Biol Ther20151510311725363342
  • SuzukiEFujitaDTakahashiMObaSNishimatsuHStem cell-derived exosomes as a therapeutic tool for cardiovascular diseaseWorld J Stem Cells2016829730527679686
  • TsaoCRLiaoMFWangMHChengCMChenCHMesenchymal stem cell derived exosomes: a new hope for the treatment of cardiovascular disease?Acta Cardiol Sin20143039540027122816
  • SuzukiEFujitaDTakahashiMObaSNishimatsuHAdult stem cells as a tool for kidney regenerationWorld J Nephrol20165435226788463
  • TanLWuHLiuYZhaoMLiDLuQRecent advances of exosomes in immune modulation and autoimmune diseasesAutoimmunity20164935736527259064
  • ZhangXYuanXShiHWuLQianHXuWExosomes in cancer: small particle, big playerJ Hematol Oncol201588326156517
  • KalaniATyagiNExosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectivesNeural Regen Res2015101565156726692841
  • XiongYMahmoodAChoppMEmerging potential of exosomes for treatment of traumatic brain injuryNeural Regen Res201712192228250732
  • KolialexiAGourgiotisDDaskalakisGValidation of serum biomarkers derived from proteomic analysis for the early screening of preeclampsiaDis Markers2015201512184825628472